ArticleJournal for immunotherapy of cancer2022

The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation.

Eva Sum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.